Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Efficacy and Safety of Sugammadex and Neostigmine in Reversing Neuromuscular Blockade
NCT04997759Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Sep 2021
- Primary completion
- Aug 2022
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Sugammadex in neuromuscular blockade (NMB) (2 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoints: Extubation time, Blood pressure variability (systolic, diastolic and mean blood pressure) and 1 more. Status: unknown.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT04997759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04997759.